(BEKE) Ke Holdings - Overview
Stock: Housing, Real Estate, Renovation, Rentals
| Risk 5d forecast | |
|---|---|
| Volatility | 38.8% |
| Relative Tail Risk | -7.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.69 |
| Alpha | -40.54 |
| Character TTM | |
|---|---|
| Beta | 0.701 |
| Beta Downside | 1.765 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.98% |
| CAGR/Max DD | -0.07 |
EPS (Earnings per Share)
Revenue
Description: BEKE Ke Holdings March 04, 2026
KE Holdings Inc. (BEKE) operates an integrated online and offline platform for housing transactions in China. This model combines digital reach with physical brokerage services, common in the Chinese real estate market due to its size and complexity.
The company segments its operations into Existing Home, New Home, Home Renovation and Furnishing, Home Rental, and Emerging and Other Services. This diversified approach covers multiple stages of the real estate lifecycle, a strategy employed by many large property service providers.
BEKE utilizes several brands, including Beike for its platform, Lianjia for brokerage stores, and Deyou for connected brokerage stores. The Agent Cooperation Network is a key component, facilitating collaboration among service providers, a critical feature in fragmented real estate markets.
Services extend beyond transactions to include rental property management and various support services like secure payment and escrow. To further understand the companys performance, consider exploring its financial statements and operational metrics on ValueRay.
Headlines to watch out for
- Chinas housing market policies directly impact transaction volumes
- New home sales commissions drive significant revenue growth
- Existing home transaction services face intense competition
- Home renovation and furnishing segment offers diversification potential
- Regulatory scrutiny on real estate platforms poses ongoing risk
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 2.99b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.82 > 1.0 |
| NWC/Revenue: 27.29% < 20% (prev 25.53%; Δ 1.76% < -1%) |
| CFO/TA 0.02 > 3% & CFO 2.91b > Net Income 2.99b |
| Net Debt (2.57b) to EBITDA (3.90b): 0.66 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.14b) vs 12m ago -3.14% < -2% |
| Gross Margin: 21.37% > 18% (prev 0.25%; Δ 2.11k% > 0.5%) |
| Asset Turnover: 75.45% > 50% (prev 70.19%; Δ 5.26% > 0%) |
| Interest Coverage Ratio: 99.25 > 6 (EBITDA TTM 3.90b / Interest Expense TTM 28.6m) |
Altman Z'' 1.68
| A: 0.22 (Total Current Assets 68.16b - Total Current Liabilities 42.43b) / Total Assets 116.74b |
| B: 0.01 (Retained Earnings 1.14b / Total Assets 116.74b) |
| C: 0.02 (EBIT TTM 2.83b / Avg Total Assets 124.95b) |
| D: 0.05 (Book Value of Equity 2.49b / Total Liabilities 49.91b) |
| Altman-Z'' Score: 1.68 = BB |
Beneish M -2.87
| DSRI: 1.01 (Receivables 5.61b/5.50b, Revenue 94.27b/93.46b) |
| GMI: 1.15 (GM 21.37% / 24.55%) |
| AQI: 1.01 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.01 (Revenue 94.27b / 93.46b) |
| TATA: 0.00 (NI 2.99b - CFO 2.91b) / TA 116.74b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of BEKE shares?
Over the past week, the price has changed by -8.76%, over one month by -8.70%, over three months by -3.32% and over the past year by -23.72%.
Is BEKE a buy, sell or hold?
- StrongBuy: 15
- Buy: 7
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BEKE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.3 | 31.9% |
| Analysts Target Price | 20.3 | 31.9% |
BEKE Fundamental Data Overview March 24, 2026
P/E Forward = 16.6945
P/S = 0.1911
P/B = 1.851
P/EG = 0.6809
Revenue TTM = 94.27b USD
EBIT TTM = 2.83b USD
EBITDA TTM = 3.90b USD
Long Term Debt = 137.9m USD (from longTermDebt, two quarters ago)
Short Term Debt = 11.37b USD (from shortTermDebt, last quarter)
Debt = 18.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.57b USD (from netDebt column, last quarter)
Enterprise Value = -18.96b USD (18.08b + Debt 18.53b - CCE 55.56b)
Interest Coverage Ratio = 99.25 (Ebit TTM 2.83b / Interest Expense TTM 28.6m)
EV/FCF = -7.79x (Enterprise Value -18.96b / FCF TTM 2.43b)
FCF Yield = -12.83% (FCF TTM 2.43b / Enterprise Value -18.96b)
FCF Margin = 2.58% (FCF TTM 2.43b / Revenue TTM 94.27b)
Net Margin = 3.17% (Net Income TTM 2.99b / Revenue TTM 94.27b)
Gross Margin = 21.37% ((Revenue TTM 94.27b - Cost of Revenue TTM 74.13b) / Revenue TTM)
Gross Margin QoQ = 21.44% (prev 21.41%)
Tobins Q-Ratio = -0.16 (set to none) (Enterprise Value -18.96b / Total Assets 116.74b)
Interest Expense / Debt = 0.15% (Interest Expense 28.6m / Debt 18.53b)
Taxrate = 36.05% (1.64b / 4.55b)
NOPAT = 1.81b (EBIT 2.83b * (1 - 36.05%))
Current Ratio = 1.61 (Total Current Assets 68.16b / Total Current Liabilities 42.43b)
Debt / Equity = 0.28 (Debt 18.53b / totalStockholderEquity, last quarter 66.48b)
Debt / EBITDA = 0.66 (Net Debt 2.57b / EBITDA 3.90b)
Debt / FCF = 1.06 (Net Debt 2.57b / FCF TTM 2.43b)
Total Stockholder Equity = 67.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.40% (Net Income 2.99b / Total Assets 116.74b)
RoE = 4.40% (Net Income TTM 2.99b / Total Stockholder Equity 67.97b)
RoCE = 4.16% (EBIT 2.83b / Capital Employed (Equity 67.97b + L.T.Debt 137.9m))
RoIC = 2.63% (NOPAT 1.81b / Invested Capital 68.87b)
WACC = 4.22% (E(18.08b)/V(36.60b) * Re(8.45%) + D(18.53b)/V(36.60b) * Rd(0.15%) * (1-Tc(0.36)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.03%
[DCF] Terminal Value 84.92% ; FCFF base≈3.54b ; Y1≈3.10b ; Y5≈2.53b
[DCF] Fair Price = 68.45 (EV 76.54b - Net Debt 2.57b = Equity 73.96b / Shares 1.08b; r=6.0% [WACC]; 5y FCF grow -15.08% → 3.0% )
EPS Correlation: 22.93 | EPS CAGR: 130.7% | SUE: -1.19 | # QB: 0
Revenue Correlation: 76.55 | Revenue CAGR: 15.99% | SUE: -0.19 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.62 | Chg7d=+0.102 | Chg30d=+0.123 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=5.75 | Chg7d=-0.280 | Chg30d=-0.446 | Revisions Net=-3 | Growth EPS=+32.5% | Growth Revenue=-5.2%
EPS next Year (2027-12-31): EPS=6.89 | Chg7d=-0.399 | Chg30d=-0.760 | Revisions Net=-3 | Growth EPS=+19.9% | Growth Revenue=+11.1%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 8.4% - Earnings Yield 2.3%)
[Growth] Growth Spread = -17.2% (Analyst -11.1% - Implied 6.1%)